Gene Symbol | Gene ID | Gene Info |
---|---|---|
Brca1
|
ENSMUSG00000017146.6 | breast cancer 1, early onset |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_101519372_101519662 | Brca1 | 2942 | 0.128966 | 0.41 | 1.8e-03 | Click! |
chr11_101519092_101519243 | Brca1 | 3292 | 0.121010 | 0.33 | 1.3e-02 | Click! |
chr11_101524555_101524706 | Brca1 | 228 | 0.858454 | 0.26 | 5.1e-02 | Click! |
chr11_101543601_101543794 | Brca1 | 7885 | 0.093989 | 0.23 | 8.8e-02 | Click! |
chr11_101519792_101519943 | Brca1 | 2592 | 0.140032 | 0.18 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_21359520_21359922 | 8.40 |
Magef1 |
melanoma antigen family F, 1 |
26365 |
0.17 |
chr3_87901211_87901576 | 7.82 |
Hdgf |
heparin binding growth factor |
4928 |
0.11 |
chr15_36580548_36581460 | 7.71 |
Gm44310 |
predicted gene, 44310 |
2540 |
0.2 |
chr16_33732337_33732520 | 7.56 |
Heg1 |
heart development protein with EGF-like domains 1 |
827 |
0.66 |
chr2_150976856_150977169 | 6.88 |
Ninl |
ninein-like |
5798 |
0.13 |
chr11_49088403_49088584 | 6.54 |
Gm12188 |
predicted gene 12188 |
50 |
0.71 |
chr15_98827590_98827953 | 6.51 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
1643 |
0.18 |
chr13_101545903_101546217 | 6.35 |
Gm47533 |
predicted gene, 47533 |
854 |
0.53 |
chr16_92825845_92826239 | 6.24 |
Runx1 |
runt related transcription factor 1 |
32 |
0.98 |
chr7_4739300_4740219 | 6.22 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr19_59905716_59906059 | 6.19 |
Gm17203 |
predicted gene 17203 |
4825 |
0.24 |
chr17_12149325_12149517 | 6.09 |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) |
2351 |
0.33 |
chr6_86660191_86660348 | 5.96 |
Mxd1 |
MAX dimerization protein 1 |
2836 |
0.15 |
chr7_110920222_110920444 | 5.93 |
Mrvi1 |
MRV integration site 1 |
3370 |
0.22 |
chr2_129232031_129232345 | 5.82 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
1609 |
0.21 |
chr17_83809218_83809497 | 5.81 |
Mta3 |
metastasis associated 3 |
13935 |
0.18 |
chr15_10399752_10400222 | 5.81 |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
41408 |
0.13 |
chr12_100955912_100956083 | 5.79 |
Ccdc88c |
coiled-coil domain containing 88C |
10824 |
0.12 |
chr6_136468328_136469393 | 5.47 |
Gm6728 |
predicted gene 6728 |
18326 |
0.12 |
chr4_128855546_128856036 | 5.38 |
Gm12968 |
predicted gene 12968 |
9594 |
0.15 |
chr13_74071260_74071584 | 5.35 |
Cep72 |
centrosomal protein 72 |
9123 |
0.15 |
chr10_5206032_5206327 | 5.33 |
Syne1 |
spectrin repeat containing, nuclear envelope 1 |
11472 |
0.28 |
chr6_137317562_137317841 | 5.25 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
65236 |
0.12 |
chr7_103825678_103825891 | 5.22 |
Hbb-bs |
hemoglobin, beta adult s chain |
1941 |
0.12 |
chr1_75445167_75446076 | 5.22 |
Gmppa |
GDP-mannose pyrophosphorylase A |
3397 |
0.11 |
chr15_62191076_62191241 | 5.18 |
Pvt1 |
Pvt1 oncogene |
12983 |
0.25 |
chr4_133390133_133390468 | 5.15 |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
19656 |
0.13 |
chr11_79753220_79753373 | 5.14 |
Mir365-2 |
microRNA 365-2 |
26896 |
0.12 |
chr4_33466883_33467152 | 5.14 |
Gm11935 |
predicted gene 11935 |
14128 |
0.21 |
chr6_35254101_35254395 | 5.13 |
1810058I24Rik |
RIKEN cDNA 1810058I24 gene |
1516 |
0.33 |
chr6_108529607_108529783 | 5.08 |
Gm44040 |
predicted gene, 44040 |
4008 |
0.18 |
chr14_121355790_121356113 | 5.06 |
Stk24 |
serine/threonine kinase 24 |
3917 |
0.25 |
chr1_170622997_170623376 | 5.04 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr12_111518372_111518678 | 5.02 |
Gm40578 |
predicted gene, 40578 |
17685 |
0.1 |
chr12_12427331_12427630 | 5.01 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
34865 |
0.22 |
chr7_103871119_103871278 | 4.99 |
Olfr66 |
olfactory receptor 66 |
11043 |
0.06 |
chr19_43797245_43797399 | 4.89 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
664 |
0.65 |
chr4_86436385_86436677 | 4.88 |
Gm12550 |
predicted gene 12550 |
5810 |
0.26 |
chr6_136857148_136857514 | 4.87 |
Art4 |
ADP-ribosyltransferase 4 |
402 |
0.71 |
chr2_79255202_79255654 | 4.86 |
Itga4 |
integrin alpha 4 |
2 |
0.98 |
chr1_189756746_189757047 | 4.78 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
28621 |
0.16 |
chr13_112073232_112073428 | 4.78 |
Gm31104 |
predicted gene, 31104 |
64786 |
0.09 |
chr17_48300203_48300827 | 4.77 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
129 |
0.94 |
chr1_91301585_91301867 | 4.77 |
Scly |
selenocysteine lyase |
1071 |
0.36 |
chr2_174329445_174331091 | 4.71 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr6_57745228_57745390 | 4.70 |
Lancl2 |
LanC (bacterial lantibiotic synthetase component C)-like 2 |
42222 |
0.09 |
chr7_90077337_90077488 | 4.66 |
Gm5341 |
predicted pseudogene 5341 |
30556 |
0.1 |
chr1_82647998_82648273 | 4.65 |
n-R5s213 |
nuclear encoded rRNA 5S 213 |
13122 |
0.16 |
chr13_119232734_119232969 | 4.61 |
Gm44488 |
predicted gene, 44488 |
36753 |
0.17 |
chr12_103737920_103738559 | 4.58 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr1_13568789_13568940 | 4.53 |
Tram1 |
translocating chain-associating membrane protein 1 |
10934 |
0.22 |
chr10_4386299_4387073 | 4.52 |
Zbtb2 |
zinc finger and BTB domain containing 2 |
789 |
0.54 |
chr1_58962981_58963145 | 4.51 |
Trak2 |
trafficking protein, kinesin binding 2 |
10366 |
0.14 |
chr11_116506385_116506879 | 4.48 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr3_157636891_157637254 | 4.48 |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
70172 |
0.09 |
chr4_46854768_46855398 | 4.44 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
4819 |
0.3 |
chr7_103813259_103814109 | 4.44 |
Hbb-bt |
hemoglobin, beta adult t chain |
312 |
0.71 |
chr3_104327151_104327314 | 4.42 |
Gm5546 |
predicted gene 5546 |
39381 |
0.12 |
chrX_101640581_101641196 | 4.41 |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) |
748 |
0.61 |
chr18_68198862_68199020 | 4.41 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
29126 |
0.15 |
chr9_14369693_14369858 | 4.41 |
Endod1 |
endonuclease domain containing 1 |
11208 |
0.12 |
chr6_5156932_5157313 | 4.37 |
Pon1 |
paraoxonase 1 |
36641 |
0.14 |
chr13_23739207_23740153 | 4.37 |
H1f2 |
H1.2 linker histone, cluster member |
872 |
0.22 |
chr10_23922650_23922801 | 4.32 |
Taar1 |
trace amine-associated receptor 1 |
2369 |
0.16 |
chr3_153852863_153853164 | 4.31 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
589 |
0.57 |
chr17_50020254_50020555 | 4.30 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
47577 |
0.13 |
chr3_154193283_154193464 | 4.29 |
Slc44a5 |
solute carrier family 44, member 5 |
29109 |
0.16 |
chr4_119895207_119895372 | 4.28 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
80794 |
0.1 |
chr6_5155101_5155310 | 4.27 |
Pon1 |
paraoxonase 1 |
38558 |
0.14 |
chr11_119834310_119834617 | 4.26 |
Rptoros |
regulatory associated protein of MTOR, complex 1, opposite strand |
98 |
0.96 |
chr7_103827316_103828207 | 4.26 |
Hbb-bs |
hemoglobin, beta adult s chain |
36 |
0.91 |
chr6_124919273_124920636 | 4.25 |
Ptms |
parathymosin |
149 |
0.88 |
chr19_17323963_17324132 | 4.23 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
11389 |
0.21 |
chr8_104434395_104434558 | 4.23 |
Gm45731 |
predicted gene 45731 |
3784 |
0.13 |
chr16_87699798_87700277 | 4.20 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
1033 |
0.58 |
chr17_24225934_24226232 | 4.19 |
Ccnf |
cyclin F |
4640 |
0.09 |
chrX_164093486_164093817 | 4.18 |
Cltrn |
collectrin, amino acid transport regulator |
1462 |
0.37 |
chr13_36460491_36460682 | 4.15 |
Gm48763 |
predicted gene, 48763 |
1306 |
0.52 |
chr5_137530580_137532081 | 4.15 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr2_84050371_84050530 | 4.15 |
Gm13692 |
predicted gene 13692 |
15837 |
0.15 |
chr10_13502373_13502723 | 4.12 |
Fuca2 |
fucosidase, alpha-L- 2, plasma |
1464 |
0.41 |
chr9_72409965_72410144 | 4.12 |
BC065403 |
cDNA sequence BC065403 |
109 |
0.87 |
chr2_26087031_26087183 | 4.12 |
Nacc2 |
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing |
3268 |
0.18 |
chr14_46597115_46597271 | 4.10 |
Rubie |
RNA upstream of Bmp4 expressed in inner ear |
1232 |
0.34 |
chr13_65011168_65011341 | 4.09 |
Gm6888 |
predicted gene 6888 |
12320 |
0.13 |
chr7_109817964_109818290 | 4.09 |
Scube2 |
signal peptide, CUB domain, EGF-like 2 |
9896 |
0.14 |
chr17_8272444_8272624 | 4.07 |
Mpc1 |
mitochondrial pyruvate carrier 1 |
10370 |
0.13 |
chr10_80572548_80572876 | 4.07 |
Klf16 |
Kruppel-like factor 16 |
4609 |
0.09 |
chr5_75460472_75460800 | 4.07 |
Gm42800 |
predicted gene 42800 |
61264 |
0.11 |
chr19_42176962_42177132 | 4.06 |
Zfyve27 |
zinc finger, FYVE domain containing 27 |
1776 |
0.24 |
chr10_41196287_41196631 | 4.06 |
Gm25526 |
predicted gene, 25526 |
19586 |
0.18 |
chr14_14351950_14353283 | 4.06 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr19_7551971_7552272 | 4.04 |
Plaat3 |
phospholipase A and acyltransferase 3 |
5338 |
0.17 |
chr7_141146101_141146426 | 4.04 |
Ptdss2 |
phosphatidylserine synthase 2 |
8360 |
0.08 |
chr18_68227583_68228114 | 4.02 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
219 |
0.94 |
chr7_49104515_49104879 | 4.01 |
Gm32849 |
predicted gene, 32849 |
19614 |
0.17 |
chr11_11684707_11686418 | 4.00 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr8_70768889_70769680 | 4.00 |
Pik3r2 |
phosphoinositide-3-kinase regulatory subunit 2 |
104 |
0.89 |
chr11_20916554_20916845 | 3.99 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr11_85298057_85298378 | 3.97 |
Ppm1d |
protein phosphatase 1D magnesium-dependent, delta isoform |
13027 |
0.18 |
chr2_78718517_78718735 | 3.97 |
Gm14463 |
predicted gene 14463 |
61197 |
0.13 |
chr5_123076757_123077212 | 3.96 |
Tmem120b |
transmembrane protein 120B |
614 |
0.54 |
chr5_65492176_65492722 | 3.95 |
Gm43552 |
predicted gene 43552 |
384 |
0.39 |
chr11_7194525_7194856 | 3.93 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
3092 |
0.22 |
chr6_102900468_102900719 | 3.93 |
Gm44429 |
predicted gene, 44429 |
36945 |
0.18 |
chr6_146219663_146219857 | 3.93 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
7783 |
0.25 |
chr10_43791761_43792071 | 3.92 |
Gm9034 |
predicted pseudogene 9034 |
29315 |
0.12 |
chr8_23094339_23094663 | 3.92 |
Ank1 |
ankyrin 1, erythroid |
1600 |
0.28 |
chr15_96699649_96700462 | 3.92 |
Gm38144 |
predicted gene, 38144 |
118 |
0.76 |
chr3_40480685_40481005 | 3.90 |
1700017G19Rik |
RIKEN cDNA 1700017G19 gene |
28929 |
0.18 |
chr4_109255748_109256041 | 3.90 |
Calr4 |
calreticulin 4 |
11312 |
0.19 |
chr7_25279370_25280622 | 3.90 |
Cic |
capicua transcriptional repressor |
355 |
0.74 |
chr6_72389445_72389953 | 3.90 |
Vamp8 |
vesicle-associated membrane protein 8 |
212 |
0.87 |
chr5_72182848_72182999 | 3.88 |
Gm42569 |
predicted gene 42569 |
10635 |
0.17 |
chr4_46404152_46404582 | 3.88 |
Hemgn |
hemogen |
131 |
0.94 |
chr10_7726045_7726439 | 3.87 |
Katna1 |
katanin p60 (ATPase-containing) subunit A1 |
234 |
0.89 |
chr19_55941321_55941745 | 3.86 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
43224 |
0.16 |
chr13_109644343_109644508 | 3.84 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
11645 |
0.32 |
chr17_71290525_71291000 | 3.83 |
Emilin2 |
elastin microfibril interfacer 2 |
6485 |
0.15 |
chr13_24551558_24551922 | 3.83 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
30449 |
0.15 |
chr13_20150160_20150481 | 3.82 |
Elmo1 |
engulfment and cell motility 1 |
34887 |
0.21 |
chr1_132364709_132365144 | 3.82 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
22 |
0.96 |
chr16_32507446_32507734 | 3.82 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
7979 |
0.13 |
chr11_4576151_4576309 | 3.80 |
Gm11960 |
predicted gene 11960 |
12598 |
0.15 |
chrX_12089963_12091553 | 3.80 |
Bcor |
BCL6 interacting corepressor |
10205 |
0.26 |
chr11_116534296_116534478 | 3.79 |
Sphk1 |
sphingosine kinase 1 |
227 |
0.83 |
chr8_84197696_84198961 | 3.79 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr11_110463651_110463811 | 3.79 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
13646 |
0.27 |
chr1_178712363_178712522 | 3.78 |
Gm34176 |
predicted gene, 34176 |
43366 |
0.17 |
chr2_84733671_84734211 | 3.77 |
Ypel4 |
yippee like 4 |
117 |
0.91 |
chr6_125572722_125573175 | 3.77 |
Vwf |
Von Willebrand factor |
6697 |
0.22 |
chr5_90689778_90690109 | 3.76 |
Rassf6 |
Ras association (RalGDS/AF-6) domain family member 6 |
49286 |
0.09 |
chr9_64953225_64953560 | 3.76 |
Slc24a1 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 |
1785 |
0.27 |
chr7_80542454_80542814 | 3.75 |
Blm |
Bloom syndrome, RecQ like helicase |
7515 |
0.17 |
chr2_19011049_19011256 | 3.74 |
4930426L09Rik |
RIKEN cDNA 4930426L09 gene |
12809 |
0.21 |
chr4_135623188_135623705 | 3.72 |
1700029M20Rik |
RIKEN cDNA 1700029M20 gene |
3209 |
0.2 |
chr17_47535479_47535650 | 3.72 |
Ccnd3 |
cyclin D3 |
30323 |
0.11 |
chr11_62148607_62148762 | 3.72 |
AL592080.1 |
sperm antigen with calponin homology and coiled-coil domains 1 (Specc1) pseudogene |
31265 |
0.16 |
chr5_151248400_151248577 | 3.71 |
5430435K18Rik |
RIKEN cDNA 5430435K18 gene |
3817 |
0.23 |
chr14_16384817_16385183 | 3.70 |
Top2b |
topoisomerase (DNA) II beta |
4577 |
0.22 |
chr2_134552444_134552595 | 3.69 |
Hao1 |
hydroxyacid oxidase 1, liver |
1788 |
0.49 |
chr15_11011266_11011421 | 3.69 |
Slc45a2 |
solute carrier family 45, member 2 |
10622 |
0.16 |
chr2_105021943_105022113 | 3.69 |
Ccdc73 |
coiled-coil domain containing 73 |
4907 |
0.17 |
chr4_106956163_106956761 | 3.69 |
Ssbp3 |
single-stranded DNA binding protein 3 |
603 |
0.76 |
chr11_64509196_64509472 | 3.68 |
Hs3st3a1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
74002 |
0.11 |
chr6_18434867_18435205 | 3.68 |
Cttnbp2 |
cortactin binding protein 2 |
585 |
0.69 |
chr4_32862579_32862778 | 3.68 |
Ankrd6 |
ankyrin repeat domain 6 |
1995 |
0.32 |
chr1_156213022_156213197 | 3.67 |
Fam163a |
family with sequence similarity 163, member A |
8083 |
0.17 |
chr17_71238518_71238794 | 3.67 |
Lpin2 |
lipin 2 |
6 |
0.97 |
chr11_54026579_54026761 | 3.66 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
1282 |
0.39 |
chr3_153690040_153690311 | 3.65 |
Gm22206 |
predicted gene, 22206 |
18736 |
0.16 |
chr10_63277050_63277215 | 3.65 |
Herc4 |
hect domain and RLD 4 |
1271 |
0.32 |
chr5_90464624_90464788 | 3.65 |
Alb |
albumin |
2006 |
0.27 |
chr1_171281492_171281879 | 3.65 |
Ppox |
protoporphyrinogen oxidase |
499 |
0.49 |
chr2_71083882_71084235 | 3.63 |
Dcaf17 |
DDB1 and CUL4 associated factor 17 |
8716 |
0.2 |
chr2_121036499_121036885 | 3.62 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr16_93131459_93131748 | 3.62 |
Gm28003 |
predicted gene, 28003 |
58848 |
0.15 |
chr11_98582037_98582236 | 3.60 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5232 |
0.11 |
chr15_9114613_9115328 | 3.58 |
Nadk2 |
NAD kinase 2, mitochondrial |
11982 |
0.18 |
chr2_160619427_160619728 | 3.58 |
Gm14221 |
predicted gene 14221 |
394 |
0.83 |
chr12_84968874_84969064 | 3.58 |
Arel1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
1855 |
0.22 |
chr2_84938621_84938923 | 3.57 |
Slc43a3 |
solute carrier family 43, member 3 |
1882 |
0.24 |
chr11_121434218_121434457 | 3.57 |
Fn3k |
fructosamine 3 kinase |
576 |
0.65 |
chr4_109445455_109445982 | 3.56 |
Ttc39a |
tetratricopeptide repeat domain 39A |
24776 |
0.14 |
chrX_56446670_56446966 | 3.55 |
Gm2174 |
predicted gene 2174 |
1147 |
0.35 |
chr7_127814109_127814554 | 3.55 |
Gm45204 |
predicted gene 45204 |
824 |
0.34 |
chr13_34287671_34288096 | 3.55 |
Gm47086 |
predicted gene, 47086 |
30925 |
0.15 |
chr11_85353309_85353655 | 3.55 |
Bcas3 |
breast carcinoma amplified sequence 3 |
270 |
0.93 |
chr2_129226918_129227069 | 3.54 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
555 |
0.51 |
chr9_63201505_63201702 | 3.54 |
Skor1 |
SKI family transcriptional corepressor 1 |
52642 |
0.12 |
chrX_164269205_164269889 | 3.54 |
Pir |
pirin |
0 |
0.96 |
chr12_105027552_105028075 | 3.53 |
Gm47650 |
predicted gene, 47650 |
150 |
0.9 |
chr4_124606233_124606577 | 3.52 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
37215 |
0.11 |
chr3_86799093_86799409 | 3.52 |
Dclk2 |
doublecortin-like kinase 2 |
91 |
0.97 |
chr11_84823504_84823973 | 3.52 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
4223 |
0.13 |
chr19_10016296_10016459 | 3.51 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
1333 |
0.3 |
chr18_32543067_32543441 | 3.50 |
Gypc |
glycophorin C |
7836 |
0.2 |
chr1_191641396_191641769 | 3.50 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr8_127257324_127257475 | 3.49 |
Pard3 |
par-3 family cell polarity regulator |
42186 |
0.2 |
chr2_73093042_73093445 | 3.49 |
Gm13665 |
predicted gene 13665 |
23505 |
0.16 |
chr8_86707705_86707856 | 3.49 |
Gm22305 |
predicted gene, 22305 |
36437 |
0.11 |
chr7_24859060_24859270 | 3.49 |
Gm18207 |
predicted gene, 18207 |
1781 |
0.17 |
chr17_39845953_39846216 | 3.48 |
CT010467.1 |
18s RNA, related sequence 5 |
269 |
0.9 |
chrX_7837240_7837456 | 3.47 |
Otud5 |
OTU domain containing 5 |
4016 |
0.1 |
chr9_58658203_58658373 | 3.46 |
Rec114 |
REC114 meiotic recombination protein |
1004 |
0.53 |
chr2_32128379_32128667 | 3.46 |
Prrc2b |
proline-rich coiled-coil 2B |
22559 |
0.1 |
chr4_97910816_97911259 | 3.46 |
Nfia |
nuclear factor I/A |
4 |
0.99 |
chr19_57894175_57894549 | 3.45 |
Mir5623 |
microRNA 5623 |
156805 |
0.04 |
chr18_20931394_20931702 | 3.45 |
Rnf125 |
ring finger protein 125 |
13077 |
0.2 |
chr14_57753296_57753601 | 3.45 |
Lats2 |
large tumor suppressor 2 |
4940 |
0.14 |
chr17_28446269_28446422 | 3.44 |
Gm22146 |
predicted gene, 22146 |
155 |
0.91 |
chr16_36893419_36893598 | 3.44 |
Gm49600 |
predicted gene, 49600 |
886 |
0.4 |
chr10_96077788_96077942 | 3.44 |
Gm49817 |
predicted gene, 49817 |
18140 |
0.18 |
chr11_115911092_115911332 | 3.43 |
Smim6 |
small integral membrane protein 6 |
805 |
0.41 |
chr3_51727985_51728369 | 3.43 |
Gm37342 |
predicted gene, 37342 |
33911 |
0.1 |
chr2_180236672_180236838 | 3.43 |
Lama5 |
laminin, alpha 5 |
10896 |
0.11 |
chr15_90224061_90224393 | 3.42 |
Alg10b |
asparagine-linked glycosylation 10B (alpha-1,2-glucosyltransferase) |
84 |
0.57 |
chr5_143060004_143060309 | 3.41 |
Gm43380 |
predicted gene 43380 |
7497 |
0.14 |
chr2_163586914_163587109 | 3.41 |
Ttpal |
tocopherol (alpha) transfer protein-like |
15303 |
0.13 |
chr11_74831594_74833056 | 3.39 |
Mnt |
max binding protein |
1405 |
0.31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 3.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.4 | 7.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.2 | 6.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.1 | 4.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.0 | 7.9 | GO:0050904 | diapedesis(GO:0050904) |
1.9 | 7.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.9 | 3.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.9 | 9.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.9 | 5.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.8 | 5.5 | GO:0036394 | amylase secretion(GO:0036394) |
1.8 | 5.4 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.7 | 8.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.7 | 10.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.6 | 4.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.6 | 4.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.6 | 4.7 | GO:0007525 | somatic muscle development(GO:0007525) |
1.6 | 4.7 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.5 | 6.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.5 | 2.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.5 | 4.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.4 | 1.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.4 | 7.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.4 | 1.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.4 | 4.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.4 | 4.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.4 | 4.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.3 | 8.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.3 | 1.3 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.3 | 3.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.3 | 7.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.3 | 2.6 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.2 | 2.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.2 | 3.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.2 | 4.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.2 | 2.5 | GO:0001555 | oocyte growth(GO:0001555) |
1.2 | 4.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.2 | 1.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.2 | 3.5 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.2 | 3.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.1 | 3.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.1 | 3.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.1 | 3.4 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 4.5 | GO:0006848 | pyruvate transport(GO:0006848) |
1.1 | 5.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.1 | 5.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.1 | 4.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.1 | 2.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.1 | 6.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 3.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.1 | 4.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.1 | 3.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.1 | 1.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.1 | 6.4 | GO:0051013 | microtubule severing(GO:0051013) |
1.1 | 4.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.0 | 4.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.0 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.0 | 4.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.0 | 1.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.0 | 3.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.0 | 3.1 | GO:0042938 | dipeptide transport(GO:0042938) |
1.0 | 3.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.0 | 1.0 | GO:0003097 | renal water transport(GO:0003097) |
1.0 | 3.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 3.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.0 | 3.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 2.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 6.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.0 | 1.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.9 | 2.8 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.9 | 3.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.9 | 0.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.9 | 3.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 3.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 2.7 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.9 | 3.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 8.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 2.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.9 | 23.7 | GO:0048821 | erythrocyte development(GO:0048821) |
0.9 | 2.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.9 | 3.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 3.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 4.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.9 | 2.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.9 | 2.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 2.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.9 | 6.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 1.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.9 | 1.7 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 2.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.8 | 2.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.8 | 1.7 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.8 | 2.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 2.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.8 | 0.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.8 | 2.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.8 | 0.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.8 | 3.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.8 | 5.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.8 | 4.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 3.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.8 | 7.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.8 | 2.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.8 | 3.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 2.3 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.8 | 3.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 2.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.7 | 2.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 4.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.7 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 2.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.7 | 3.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.7 | 5.2 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.7 | 1.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 2.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 2.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 5.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.7 | 4.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.7 | 5.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.7 | 2.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 5.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.7 | 2.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 4.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.7 | 5.7 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.7 | 2.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.7 | 2.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.7 | 2.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.7 | 3.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.7 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 2.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.7 | 3.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 2.8 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 2.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.7 | 3.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.7 | 2.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.7 | 1.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 2.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.7 | 2.1 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.7 | 4.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.7 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.7 | 2.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.7 | 0.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.7 | 2.7 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.7 | 2.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.7 | 4.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.7 | 2.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.7 | 2.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 0.7 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.7 | 2.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.7 | 9.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.7 | 2.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 1.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.7 | 2.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.7 | 1.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.7 | 1.3 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.7 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.6 | 0.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.6 | 1.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 5.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.6 | 2.6 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 3.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.6 | 2.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 2.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 2.5 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.6 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 1.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 1.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.6 | 1.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 1.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 0.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.6 | 0.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.6 | 3.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 1.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.6 | 2.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 1.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.6 | 0.6 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.6 | 1.2 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.6 | 1.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.6 | 3.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 4.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 2.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 1.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.6 | 1.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 1.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.6 | 2.4 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.6 | 1.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 2.4 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.6 | 1.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.6 | 2.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 5.4 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.6 | 2.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.6 | 14.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.6 | 3.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 3.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 4.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 1.8 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 3.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.6 | 5.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.6 | 2.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.6 | 4.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.6 | 1.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 2.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.6 | 1.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.6 | 6.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 0.6 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 2.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.6 | 4.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 1.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 5.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 2.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.6 | 1.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 6.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 2.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.6 | 2.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 3.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.6 | 3.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 1.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.6 | 2.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 3.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 2.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 4.5 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.6 | 2.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 5.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 3.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.6 | 1.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 14.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 2.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 1.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.6 | 3.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.6 | 0.6 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.5 | 1.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.5 | 1.1 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.5 | 2.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 4.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 2.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.5 | 4.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 8.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.5 | 2.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 2.2 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.5 | 2.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 0.5 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.5 | 2.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 2.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 1.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 4.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.5 | 0.5 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.5 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.6 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.5 | 1.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.5 | 1.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 1.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.5 | 3.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 1.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 1.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 2.6 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.5 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 1.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.5 | 3.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 2.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 0.5 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.5 | 0.5 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 2.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.5 | 1.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 7.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 1.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.5 | 0.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.5 | 7.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.5 | 2.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 2.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.5 | 1.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 1.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 2.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 2.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 5.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 1.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.5 | 1.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 1.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 4.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 2.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 0.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 3.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 4.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 2.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 3.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 1.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.5 | 3.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 1.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.5 | 2.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.5 | 1.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 2.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 1.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 1.5 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.5 | 1.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.5 | 1.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.5 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 0.5 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.5 | 1.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 3.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.5 | 1.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 1.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 1.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.5 | 1.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.5 | 0.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 1.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.5 | 1.9 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 3.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 3.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 4.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 1.4 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 1.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 2.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 2.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 1.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 0.5 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.5 | 1.4 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 1.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 1.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 1.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.5 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 2.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.5 | 4.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 2.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 2.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.5 | 0.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 0.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.5 | 4.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.5 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 4.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 1.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.8 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.4 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 0.9 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.4 | 0.9 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.4 | 1.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 1.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 1.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 5.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 1.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 0.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.4 | 0.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 5.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 3.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 1.8 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.4 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 4.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.4 | 1.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 3.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 1.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 1.3 | GO:0051304 | chromosome separation(GO:0051304) |
0.4 | 1.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 2.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 5.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 1.3 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.4 | 1.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.7 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.4 | 5.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 13.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.4 | 2.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 2.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 2.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.4 | 0.4 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.4 | 2.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 1.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 1.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 0.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 2.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 0.4 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) |
0.4 | 2.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 1.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.8 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.4 | 1.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.8 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 2.9 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 6.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.2 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.4 | 2.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 1.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.4 | 2.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 1.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 5.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 0.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.4 | 0.8 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.4 | 0.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 2.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 2.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.4 | 1.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 1.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 1.2 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 0.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.4 | 0.4 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.4 | 1.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 0.8 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 6.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 3.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.4 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 0.8 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 1.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 6.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.4 | 2.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 1.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.4 | 0.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 3.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.4 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 3.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 4.1 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 1.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 4.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 1.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 2.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 2.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.9 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.8 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.4 | 1.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 4.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 1.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 5.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 0.4 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 1.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.4 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 4.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 1.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.7 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 0.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.4 | 3.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 2.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.4 | 1.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 1.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 0.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 3.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.4 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.7 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 1.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 2.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 1.7 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 1.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 1.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 1.7 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.3 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 3.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.3 | 0.3 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 1.0 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 4.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 3.1 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 0.3 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 1.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.3 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 4.0 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 2.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 3.0 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.3 | 1.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.3 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 1.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.3 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 2.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 1.3 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 1.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 6.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.7 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.3 | 0.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 2.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 2.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.3 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.3 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 1.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 2.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 4.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 1.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 2.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 1.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 1.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 2.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 0.6 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.0 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 7.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 2.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.3 | 5.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.9 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 0.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 0.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 3.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 1.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 2.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 1.8 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 2.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 0.3 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 1.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 0.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 1.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.9 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.3 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.9 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.3 | 0.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.3 | 0.9 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 0.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 0.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 2.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 3.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 0.9 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 0.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.3 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.6 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.3 | 6.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.6 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.3 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 1.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 3.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 2.9 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.3 | 0.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.1 | GO:0009838 | abscission(GO:0009838) |
0.3 | 1.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 1.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.3 | 1.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 1.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 16.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 1.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 3.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 4.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 4.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.6 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.3 | 1.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.8 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.3 | 0.5 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 1.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.3 | 2.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.8 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 2.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 1.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 1.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 2.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 4.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.8 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 3.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.5 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 2.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 1.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 13.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 0.5 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.3 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 1.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 0.3 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.3 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.3 | 10.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 5.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.5 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 1.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.5 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.3 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.3 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.3 | 2.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 2.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 0.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 3.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.8 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 3.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 1.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.2 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.7 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 6.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.2 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 1.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 2.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 1.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 1.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 1.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.7 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.2 | 0.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 2.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 1.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.5 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 2.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.5 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 4.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.5 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.2 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 1.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 1.4 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.2 | 0.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 2.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 2.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 1.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 2.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 3.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 1.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 2.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.9 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 4.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 1.8 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 0.9 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 2.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 7.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.7 | GO:0031468 | mitotic nuclear envelope reassembly(GO:0007084) nuclear envelope reassembly(GO:0031468) |
0.2 | 0.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.4 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 1.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 2.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 2.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 3.8 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.2 | 0.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.2 | 0.7 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.2 | 0.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 2.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 8.1 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 2.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 3.7 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 3.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 4.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 5.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 7.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.7 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.6 | GO:0071941 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
0.2 | 0.4 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.6 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 2.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 2.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 4.1 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 2.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 11.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.6 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.2 | 1.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 0.4 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.2 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 1.6 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.2 | 1.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.6 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 1.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 2.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.2 | 1.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 2.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 3.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 1.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.8 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.6 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 1.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 3.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.2 | 0.4 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 1.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 1.7 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.2 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.2 | 0.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 3.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 1.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 4.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.2 | 3.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 1.7 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.7 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 3.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 5.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 1.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 5.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.2 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 3.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 1.4 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.4 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.2 | 2.6 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.5 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 1.0 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.2 | 1.7 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 1.0 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.2 | 1.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 5.5 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.2 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 7.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.3 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.2 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 2.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 4.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.7 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.2 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.5 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.7 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 0.2 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.2 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.2 | 1.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.3 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.2 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 6.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.2 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 1.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 2.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.2 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.2 | 0.8 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.8 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.2 | 0.6 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.2 | 4.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 1.1 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 1.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.1 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 0.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 1.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.6 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.1 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 2.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 5.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 1.3 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 1.2 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 2.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 1.2 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.1 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 1.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 1.5 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 5.1 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 3.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 1.6 | GO:0070192 | chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.1 | 1.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 2.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 2.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 1.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.1 | 22.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.1 | 0.9 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 1.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.5 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 3.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.6 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 1.1 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.1 | 0.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 4.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 2.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.1 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 4.4 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 2.3 | GO:0044839 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.5 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.4 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.5 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.5 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.3 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.4 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 1.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 2.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.5 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.4 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 6.6 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.3 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 1.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.2 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 17.1 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.6 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 1.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 3.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.5 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.7 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 1.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 1.2 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 2.8 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.1 | 0.2 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.8 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 2.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:1902884 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 1.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 1.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 1.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.7 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.0 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.7 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.2 | GO:0032438 | melanosome organization(GO:0032438) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.8 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 0.0 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 1.1 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.0 | GO:1903050 | regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
0.0 | 0.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.0 | 0.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.3 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:0042701 | progesterone secretion(GO:0042701) |
0.0 | 0.0 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.2 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.0 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.8 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 15.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.3 | 2.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.8 | 5.3 | GO:0000811 | GINS complex(GO:0000811) |
1.3 | 6.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.2 | 3.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.2 | 7.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.2 | 3.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 4.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.2 | 4.7 | GO:1990130 | Iml1 complex(GO:1990130) |
1.2 | 3.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.1 | 3.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 6.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.9 | 4.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 3.7 | GO:0042825 | TAP complex(GO:0042825) |
0.9 | 2.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.9 | 2.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.8 | 8.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.8 | 6.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.8 | 3.3 | GO:0030689 | Noc complex(GO:0030689) |
0.8 | 3.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.8 | 3.2 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 3.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 4.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 3.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 3.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 3.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.7 | 3.7 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 2.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.7 | 5.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 6.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 1.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.7 | 2.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.7 | 6.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 2.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 10.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.7 | 2.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.7 | 9.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 4.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 2.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 1.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 2.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.6 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 0.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 2.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 2.5 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 2.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 6.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 1.8 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 6.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.6 | 1.8 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 1.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.6 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 1.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 2.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 2.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 4.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 4.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.5 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 1.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 3.3 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 4.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 1.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 2.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 4.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 2.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 1.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 3.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 8.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 2.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 3.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 4.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 15.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 5.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 1.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 3.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 4.8 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 1.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 3.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 1.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 1.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 39.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 2.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 1.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 2.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 8.5 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 4.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 1.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 15.2 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 25.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 1.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 3.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 2.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 3.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 2.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 2.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 5.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 11.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 2.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 4.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 6.0 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.2 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 2.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 3.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 5.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 11.8 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 1.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 1.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 1.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 19.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 7.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 1.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 4.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 3.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 2.6 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 14.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 4.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.4 | 1.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 2.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 2.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 2.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 35.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.4 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 5.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 9.0 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 15.8 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 4.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 2.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 5.4 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 3.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 3.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 4.3 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 1.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 11.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 2.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 0.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 2.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 5.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 2.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 1.5 | GO:0005818 | aster(GO:0005818) |
0.3 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 2.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 2.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 2.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 0.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 1.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 5.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 3.7 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 4.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 2.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 2.2 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 4.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 3.3 | GO:0002102 | podosome(GO:0002102) |
0.3 | 2.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 5.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 12.8 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 20.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 2.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 2.9 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 4.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 3.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.5 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 2.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 2.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 2.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 16.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 15.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 4.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.5 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 9.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 8.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 4.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.4 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 3.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 11.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 4.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.1 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 5.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 1.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 4.0 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.7 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 11.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.2 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 8.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 5.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 65.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 2.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 5.6 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.2 | 1.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 2.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 12.0 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 1.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 2.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 4.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.2 | 3.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.8 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.8 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.2 | 3.6 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 0.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 1.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 2.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 25.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 2.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 3.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 6.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 12.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 1.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 9.6 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.9 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 2.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 2.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 2.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 4.8 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.8 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 1.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 5.0 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 3.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 3.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 3.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 13.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 104.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 3.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 2.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 17.3 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 128.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 11.7 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 4.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 11.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 3.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 67.0 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 5.5 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 2.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 6.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 55.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 11.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.3 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 9.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.6 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 3.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 5.8 | GO:0031981 | nuclear lumen(GO:0031981) |
0.0 | 0.0 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 3.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 13.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.1 | 2.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.1 | 6.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.7 | 5.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.5 | 6.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.4 | 7.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.4 | 4.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.2 | 3.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.2 | 4.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 2.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.2 | 3.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 2.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.2 | 3.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.2 | 3.5 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.2 | 3.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.1 | 5.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.1 | 5.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.1 | 3.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.1 | 5.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.1 | 3.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.1 | 3.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 4.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.0 | 6.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.0 | 3.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 5.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 5.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.0 | 7.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.0 | 3.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.0 | 2.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.0 | 3.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.0 | 2.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.9 | 2.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.9 | 3.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.9 | 2.8 | GO:0032564 | dATP binding(GO:0032564) |
0.9 | 6.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.9 | 2.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 2.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.9 | 2.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.9 | 5.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.9 | 2.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 3.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.9 | 3.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.9 | 4.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.9 | 3.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.9 | 3.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 5.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.8 | 0.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.8 | 5.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 4.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.8 | 4.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 2.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.8 | 6.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 3.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 2.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 6.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 3.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.8 | 2.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 3.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 3.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.7 | 3.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.7 | 2.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.7 | 9.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.7 | 2.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 6.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 2.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 2.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 3.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.7 | 5.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 0.7 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.7 | 2.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 8.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 3.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.7 | 3.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 2.0 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 4.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 2.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 4.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.7 | 2.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.7 | 5.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 2.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.6 | 1.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 13.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.6 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 1.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 3.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 6.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 5.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.6 | 2.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 1.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 4.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 1.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 1.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.6 | 2.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 3.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 1.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 1.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.6 | 5.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 1.7 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.6 | 2.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 4.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.6 | 1.7 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.6 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 4.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.6 | 2.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 2.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 3.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 11.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 2.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 3.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.6 | 10.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 1.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 2.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 1.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 12.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 2.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 1.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 2.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 12.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 2.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 1.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 1.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 6.8 | GO:0019825 | oxygen binding(GO:0019825) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 14.1 | GO:0052635 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.5 | 1.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 1.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 2.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 1.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 4.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 1.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.5 | 3.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 3.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 3.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 4.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 2.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 14.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 0.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 1.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 4.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 2.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 2.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 1.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 1.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 1.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 1.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 3.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 1.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 1.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 21.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 2.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 4.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 1.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 1.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 9.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 3.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 3.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 0.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 4.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 2.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 3.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 1.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 2.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 0.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 1.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 8.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 8.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 1.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.4 | 1.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 2.1 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 4.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 1.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 3.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 7.4 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 4.5 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 2.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 3.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 2.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 0.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 5.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 1.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.9 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 0.8 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 3.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 2.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 1.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 1.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 7.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 3.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 3.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 3.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 3.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 2.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 0.7 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.4 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 10.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 0.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 6.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 1.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 2.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 2.8 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 4.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 2.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 10.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 1.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 11.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 3.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 1.0 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 4.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 2.4 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.3 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 2.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 5.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 3.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 1.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 5.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 2.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 4.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 11.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 2.3 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 2.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 4.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 10.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 3.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 5.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 2.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 10.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 2.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 0.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 3.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 2.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.3 | 5.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 1.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 1.6 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 4.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 2.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 0.9 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 2.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.9 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 0.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 4.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 23.2 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 6.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 5.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 0.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 2.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 0.3 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.3 | 1.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 3.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 2.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 0.9 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 3.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 2.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 2.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 2.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 1.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.3 | 8.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 5.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 0.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 3.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 2.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 6.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 0.5 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 7.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 8.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 3.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 5.8 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 2.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 0.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 0.8 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 0.8 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 3.9 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 2.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 0.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 9.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 1.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 2.5 | GO:0008828 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 1.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 5.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 4.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 2.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.7 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 1.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 2.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 16.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 1.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 1.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 2.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 34.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 4.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 2.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 3.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 2.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 5.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 10.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 3.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 1.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 2.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 3.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 3.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 2.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 3.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 2.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 8.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 4.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 3.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 2.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 28.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.6 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 2.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 17.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 36.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 4.9 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.4 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.2 | 4.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 10.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 2.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 4.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 2.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 2.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 4.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.2 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 3.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 7.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 3.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 3.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 2.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.4 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 2.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 5.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.5 | GO:0018599 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 12.5 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 2.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 4.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 1.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.2 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 5.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 4.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 9.4 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.2 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 7.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.3 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.2 | 2.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 14.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.9 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 3.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 5.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 13.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 4.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 9.8 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 6.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 68.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 2.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 1.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 4.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 10.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.3 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.6 | GO:0016894 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 1.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.8 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 4.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 4.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.2 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 3.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.7 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.7 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 1.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 7.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.5 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 1.5 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 3.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.0 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.5 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 5.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.0 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 2.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 11.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 10.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 10.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 15.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 4.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 9.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 9.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 22.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 6.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 1.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 19.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 13.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 19.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 6.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 1.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 6.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 9.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 4.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 12.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 13.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 3.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 14.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 9.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 4.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 4.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 12.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 14.1 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 15.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 7.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 3.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 3.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 9.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 9.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 1.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 5.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 4.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 9.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 6.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 6.8 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 1.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 2.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 3.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 5.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 1.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.0 | 10.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.0 | 11.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 6.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 12.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 3.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.8 | 9.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 2.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 6.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 3.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 15.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 7.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 5.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 7.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 17.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 3.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 0.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 7.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.6 | 0.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 8.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 8.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 8.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 12.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 5.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 13.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 5.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 5.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 1.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 11.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 7.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 6.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.5 | 2.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 15.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.5 | 4.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 7.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 22.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 5.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 3.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 2.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 13.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 4.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 2.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 27.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 3.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 6.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 2.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 5.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 4.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 7.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 3.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 3.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 6.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 10.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 3.0 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.4 | 5.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 8.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 1.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 5.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 3.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 3.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 5.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 5.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 1.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 4.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 4.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 3.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 7.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 3.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 3.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 8.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 16.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 3.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 4.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 0.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 5.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 8.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 1.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 1.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 4.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.3 | 1.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 3.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 10.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 9.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 12.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 1.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 2.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.3 | 27.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 7.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 9.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 24.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 1.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 9.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.3 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 5.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 3.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 2.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 2.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 3.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.3 | 1.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.3 | 3.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 3.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 6.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 4.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 16.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 4.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 2.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 2.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 5.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 12.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 9.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 2.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 3.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 2.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 17.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 4.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 9.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 1.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 10.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 2.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 2.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.8 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 7.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 2.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 4.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 2.0 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.2 | 0.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 2.5 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.2 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.9 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.2 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 16.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 2.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 3.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 5.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 7.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.1 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 2.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 1.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |